ICH E6 (R2) demands that risk identification and mitigation steps are clearly documented throughout the lifecycle of a clinical trial. Our blueprint helps to ensure the start of a successful CRO partnership.

The first step to any successful CRO engagement is a successful kickoff meeting – get that wrong and the entire clinical trial can go sideways, costing precious time and money. Follow our blueprint to lower risks, increase inspection readiness, and develop clear documentation for compliance.

Utilization of this tool assists with:

• ICH E6 (R2) compliance
• CRO/FSP oversight
• Lower risk and cost
• Increased inspection readiness

Avoca Quality Consortium

The Avoca Quality Consortium™ (AQC) is a member-based pre-competitive collaborative comprised of clinical operations, quality, and outsourcing professionals from pharma, biotech, CROs, and clinical service providers. The AQC is founded on a commitment to improve outsourced clinical trials.